You are here
- Home
- Media
- Press releases
- 2001
ASTRAZENECA APPOINTS NEW NON - EXECUTIVE DIRECTOR
- Reference code :
- wf395
- Published date :
-
25 July 2001
- Expired date :
-
10 December 2028
AstraZeneca PLC announces the appointment, with effect from 24 September 2001, of Jane E. Henney, M.D. as a non-executive Director.
Dr Henney has considerable expertise and experience in US Healthcare matters. Currently, she is a Senior Scholar at the Association of Academic Health Centres. Prior to this appointment she was the Commissioner of Food and Drugs, U.S. Food and Drug Administration from 1998 – 2001. She was also Deputy Commissioner for Operations at the FDA from 1992-1994. She is a medical oncologist and has held several posts at the National Cancer Institute including Deputy Director from 1980 -1995. Her past academic positions include Vice President for Health Sciences at the University of New Mexico and Vice President for Health Programmes and Policy and Interim Dean of the School of Medicine at the University of Kansas Medical Centre.
Further enquires to:
Media RelationsSteve Brown +44 (0)20 7304 5033 Anna Isaacs +44 (0)20 7304 5034 Rachel Bloom +1 302 886 7858 |
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD - Stockholm
-
310.10 SEK
At 21-Nov-2009 07:01 GMT
Detailed share priceIntroduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
